Any 0 3 0 3 O
immunosuppressive 4 21 4 21 B-treatment
treatment 22 31 22 31 I-treatment
including 32 41 32 41 O
but 42 45 42 45 O
not 46 49 46 49 O
limited 50 57 50 57 O
to 58 60 58 60 O
methotrexate 61 73 61 73 B-treatment
, 73 74 73 74 O
cyclosporine 75 87 75 87 B-treatment
, 87 88 87 88 O
mycophenolate 89 102 89 102 B-treatment
, 102 103 102 103 O
tacrolimus 104 114 104 114 B-treatment
, 114 115 114 115 O
gold 116 120 116 120 B-treatment
, 120 121 120 121 O
penicillamine 122 135 122 135 B-treatment
, 135 136 135 136 O
sulfasalazine 137 150 137 150 B-treatment
, 150 151 150 151 O
hydroxychloroquine 152 170 152 170 B-treatment
, 170 171 170 171 O
azathioprine 172 184 172 184 B-treatment
, 184 185 184 185 O
and 186 189 186 189 O
cyclophosphamide 190 206 190 206 B-treatment
in 207 209 207 209 O
the 210 213 210 213 O
last 214 218 214 218 B-upper_bound
two 219 222 219 222 I-upper_bound
weeks 223 228 223 228 I-upper_bound
before 229 235 229 235 O
starting 236 244 236 244 O
treatment 245 254 245 254 O

Any 0 3 255 258 O
use 4 7 259 262 O
of 8 10 263 265 O
nonsteroidal 11 23 266 278 B-treatment
anti 24 28 279 283 I-treatment
- 28 29 283 284 I-treatment
inflammatory 29 41 284 296 I-treatment
drugs 42 47 297 302 I-treatment
( 48 49 303 304 I-treatment
NSAIDs 49 55 304 310 I-treatment
) 55 56 310 311 I-treatment
or 57 59 312 314 O
any 60 63 315 318 O
drug 64 68 319 323 O
that 69 73 324 328 O
inhibits 74 82 329 337 O
the 83 86 338 341 O
cyclooxygenase 87 101 342 356 B-treatment
enzyme 102 108 357 363 I-treatment
in 109 111 364 366 O
the 112 115 367 370 O
last 116 120 371 375 B-upper_bound
two 121 124 376 379 I-upper_bound
weeks 125 130 380 385 I-upper_bound
before 131 137 386 392 O
starting 138 146 393 401 O
treatment 147 156 402 411 B-treatment

Current 0 7 412 419 B-pregnancy
pregnancy 8 17 420 429 I-pregnancy

Daily 0 5 430 435 O
use 6 9 436 439 O
of 10 12 440 442 O
long 13 17 443 447 O
- 17 18 447 448 O
acting 18 24 448 454 O
antihistamines 25 39 455 469 B-treatment
in 40 42 470 472 O
the 43 46 473 476 O
last 47 51 477 481 B-upper_bound
two 52 55 482 485 I-upper_bound
weeks 56 61 486 491 I-upper_bound
before 62 68 492 498 O
starting 69 77 499 507 O
treatment 78 87 508 517 B-treatment

Endoscopic 0 10 518 528 B-treatment
sinus 11 16 529 534 I-treatment
surgery 17 24 535 542 I-treatment
/ 25 26 543 544 O
polypectomy 27 38 545 556 B-treatment
within 39 45 557 563 O
the 46 49 564 567 O
past 50 54 568 572 B-upper_bound
three 55 60 573 578 I-upper_bound
months 61 67 579 585 I-upper_bound

Exhibit 0 7 586 593 O
symptomatic 8 19 594 605 O
AERD 20 24 606 610 B-chronic_disease
within 25 31 611 617 O
three 32 37 618 623 B-upper_bound
weeks 38 43 624 629 I-upper_bound
of 44 46 630 632 O
starting 47 55 633 641 O
treatment 56 65 642 651 B-treatment
by 66 68 652 654 O
demonstrating 69 82 655 668 O
a 83 84 669 670 O
score 85 90 671 676 O
of 91 93 677 679 O
at 94 96 680 682 O
least 97 102 683 688 O
20 103 105 689 691 B-lower_bound
on 106 108 692 694 O
the 109 112 695 698 O
Sino 113 117 699 703 B-clinical_variable
- 117 118 703 704 I-clinical_variable
nasal 118 123 704 709 I-clinical_variable
Outcome 124 131 710 717 I-clinical_variable
Test 132 136 718 722 I-clinical_variable
( 137 138 723 724 I-clinical_variable
SNOT 138 142 724 728 I-clinical_variable
) 142 143 728 729 I-clinical_variable
- 144 145 730 731 I-clinical_variable
22 146 148 732 734 I-clinical_variable

History 0 7 735 742 O
of 8 10 743 745 O
at 11 13 746 748 O
least 14 19 749 754 O
two 20 23 755 758 O
reactions 24 33 759 768 O
to 34 36 769 771 O
oral 37 41 772 776 B-treatment
aspirin 42 49 777 784 I-treatment
or 50 52 785 787 O
other 53 58 788 793 O
nonselective 59 71 794 806 O
cyclooxygenase 72 86 807 821 O
inhibitor 87 96 822 831 O
with 97 101 832 836 O
features 102 110 837 845 O
of 111 113 846 848 O
lower 114 119 849 854 O
airway 120 126 855 861 O
involvement 127 138 862 873 O
( 139 140 874 875 O
cough 140 145 875 880 O
, 145 146 880 881 O
chest 147 152 882 887 O
tightness 153 162 888 897 O
, 162 163 897 898 O
wheezing 164 172 899 907 O
, 172 173 907 908 O
dyspnea 174 181 909 916 O
) 181 182 916 917 O
, 182 183 917 918 O
or 184 186 919 921 O
one 187 190 922 925 O
reaction 191 199 926 934 O
that 200 204 935 939 O
was 205 208 940 943 O
life 209 213 944 948 O
- 213 214 948 949 O
threatening 214 225 949 960 O
and 226 229 961 964 O
required 230 238 965 973 O
hospitalization 239 254 974 989 O
, 254 255 989 990 O
or 256 258 991 993 O
a 259 260 994 995 O
diagnosis 261 270 996 1005 O
of 271 273 1006 1008 O
AERD 274 278 1009 1013 O
by 279 281 1014 1016 O
a 282 283 1017 1018 O
physician 284 293 1019 1028 O
- 293 294 1028 1029 O
conducted 294 303 1029 1038 O
challenge 304 313 1039 1048 O
to 314 316 1049 1051 O
aspirin 317 324 1052 1059 O
in 325 327 1060 1062 O
the 328 331 1063 1066 O
last 332 336 1067 1071 B-upper_bound
five 337 341 1072 1076 I-upper_bound
years 342 347 1077 1082 I-upper_bound
before 348 354 1083 1089 O
starting 355 363 1090 1098 O
treatment 364 373 1099 1108 B-treatment

History 0 7 1109 1116 O
of 8 10 1117 1119 O
bleeding 11 19 1120 1128 B-chronic_disease
diathesis 20 29 1129 1138 I-chronic_disease

History 0 7 1139 1146 O
of 8 10 1147 1149 O
nasal 11 16 1150 1155 B-chronic_disease
polyposis 17 26 1156 1165 I-chronic_disease

History 0 7 1166 1173 O
of 8 10 1174 1176 O
physician 11 20 1177 1186 O
- 20 21 1186 1187 O
diagnosed 21 30 1187 1196 O
asthma 31 37 1197 1203 B-chronic_disease

Less 0 4 1204 1208 O
than 5 9 1209 1213 O
1 10 11 1214 1215 B-upper_bound
month 12 17 1216 1221 I-upper_bound
of 18 20 1222 1224 O
5 21 22 1225 1226 O
- 22 23 1226 1227 O
lipoxygenase 23 35 1227 1239 O
inhibitors 36 46 1240 1250 O
( 47 48 1251 1252 O
e.g. 48 52 1252 1256 O
zileuton 53 61 1257 1265 O
) 61 62 1265 1266 O
and/or 63 69 1267 1273 O
leukotriene 70 81 1274 1285 O
receptor 82 90 1286 1294 O
antagonists 91 102 1295 1306 O
( 103 104 1307 1308 O
e.g. 104 108 1308 1312 O
montelukast 109 120 1313 1324 B-treatment
) 120 121 1324 1325 O

Stable 0 6 1326 1332 O
asthma 7 13 1333 1339 B-chronic_disease

Use 0 3 1340 1343 O
of 4 6 1344 1346 O
oral 7 11 1347 1351 B-treatment
or 12 14 1352 1354 O
systemic 15 23 1355 1363 B-treatment
steroids 24 32 1364 1372 I-treatment
( 33 34 1373 1374 O
e.g. 34 38 1374 1378 O
prednisone 39 49 1379 1389 B-treatment
or 50 52 1390 1392 O
equivalent 53 63 1393 1403 O
) 63 64 1403 1404 O
> 65 66 1405 1406 O
20 67 69 1407 1409 B-lower_bound
mg 70 72 1410 1412 I-lower_bound
daily 73 78 1413 1418 O
in 79 81 1419 1421 O
the 82 85 1422 1425 O
last 86 90 1426 1430 B-upper_bound
four 91 95 1431 1435 I-upper_bound
weeks 96 101 1436 1441 I-upper_bound
before 102 108 1442 1448 O
starting 109 117 1449 1457 O
treatment 118 127 1458 1467 O

daily 0 5 1468 1473 O
tobacco 6 13 1474 1481 O
smoking 14 21 1482 1489 O
in 22 24 1490 1492 O
the 25 28 1493 1496 O
last 29 33 1497 1501 B-upper_bound
six 34 37 1502 1505 I-upper_bound
months 38 44 1506 1512 I-upper_bound
and 45 48 1513 1516 O
at 49 51 1517 1519 O
least 52 57 1520 1525 O
one 58 61 1526 1529 B-lower_bound
instance 62 70 1530 1538 O
of 71 73 1539 1541 O
tobacco 74 81 1542 1549 O
smoking 82 89 1550 1557 O
in 90 92 1558 1560 O
the 93 96 1561 1564 O
last 97 101 1565 1569 B-upper_bound
three 102 107 1570 1575 I-upper_bound
months 108 114 1576 1582 I-upper_bound

maintenance 0 11 1583 1594 O
dose 12 16 1595 1599 O
of 17 19 1600 1602 O
allergy 20 27 1603 1610 O
shots 28 33 1611 1616 O
are 34 37 1617 1620 O
allowed 38 45 1621 1628 O
if 46 48 1629 1631 O
treatment 49 58 1632 1641 O
duration 59 67 1642 1650 O
exceeds 68 75 1651 1658 O
12 76 78 1659 1661 B-lower_bound
months 79 85 1662 1668 I-lower_bound

no 0 2 1669 1671 O
glucocorticoid 3 17 1672 1686 B-treatment
burst 18 23 1687 1692 O
for 24 27 1693 1696 O
at 28 30 1697 1699 O
least 31 36 1700 1705 O
two 37 40 1706 1709 B-lower_bound
weeks 41 46 1710 1715 I-lower_bound
prior 47 52 1716 1721 I-lower_bound
to 53 55 1722 1724 O
starting 56 64 1725 1733 O
treatment 65 74 1734 1743 B-treatment

no 0 2 1744 1746 O
hospitalizations 3 19 1747 1763 O
or 20 22 1764 1766 O
emergency 23 32 1767 1776 O
room 33 37 1777 1781 O
visits 38 44 1782 1788 O
for 45 48 1789 1792 O
asthma 49 55 1793 1799 B-chronic_disease
at 56 58 1800 1802 O
least 59 64 1803 1808 O
three 65 70 1809 1814 B-lower_bound
months 71 77 1815 1821 I-lower_bound
prior 78 83 1822 1827 I-lower_bound
to 84 86 1828 1830 O
starting 87 95 1831 1839 O
treatment 96 105 1840 1849 O

not 0 3 1850 1853 O
on 4 6 1854 1856 O
a 7 8 1857 1858 O
dose 9 13 1859 1863 O
> 14 15 1864 1865 O
1000 15 19 1865 1869 B-lower_bound
µg 20 22 1870 1872 I-lower_bound
fluticasone 23 34 1873 1884 B-treatment
or 35 37 1885 1887 O
equivalent 38 48 1888 1898 O
daily 49 54 1899 1904 O

post 0 4 1905 1909 B-clinical_variable
- 4 5 1909 1910 I-clinical_variable
bronchodilator 5 19 1910 1924 I-clinical_variable
FEV1 20 24 1925 1929 I-clinical_variable
of 25 27 1930 1932 O
≥ 28 29 1933 1934 O
60 30 32 1935 1937 B-lower_bound
% 32 33 1937 1938 I-lower_bound

use 0 3 1939 1942 O
of 4 6 1943 1945 O
anticoagulant 7 20 1946 1959 B-treatment
or 21 23 1960 1962 O
antiplatelet 24 36 1963 1975 B-treatment
drugs 37 42 1976 1981 I-treatment
in 43 45 1982 1984 O
the 46 49 1985 1988 O
last 50 54 1989 1993 B-upper_bound
two 55 58 1994 1997 I-upper_bound
weeks 59 64 1998 2003 I-upper_bound
before 65 71 2004 2010 O
starting 72 80 2011 2019 O
treatment 81 90 2020 2029 O

